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Background/Aims: Gastric epithelial dysplasia is considered 
a precancerous lesion with a variable clinical course. There is 
disagreement, however, regarding histology-based diagnoses, 
which has led to confusion in choosing a therapeutic plan. 
New objective markers are needed to determine which lesions 
progress to true malignancy. We measured LINE-1 methylation 
levels, which have been reported to strongly correlate with the 
global methylation level in gastric epithelial dysplasia and in-
tramucosal cancer. Methods: A total of 145 tissue samples were 
analyzed by two histopathologists. All tissues were excised by 
therapeutic endoscopic mucosal resection and paired with adja-
cent normal tissue samples. A modified long interspersed nucle-
otide elements–combined bisulfite restriction analysis (COBRA-
LINE-1) method was used. Results: Gastric epithelial dysplasia 
and intramucosal cancer tissues had significantly lower levels of 
LINE-1 methylation than adjacent normal gastric tissues. High-
grade dysplasia and intramucosal cancer were distinguishable 
from low-grade dysplasia based on LINE-1 methylation levels. 
Furthermore, the distinction could be determined with high 
sensitivity and specificity, as shown by the receiver operating 
characteristic (ROC) curve (AUC, 0.82; 95% confidence interval, 
0.74 to 0.88). Conclusions: LINE-1 methylation levels may pro-
vide a diagnostic tool for identifying high-grade dysplasia and 
intramucosal cancer. (Gut Liver 2011;5:149-153)
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INTRODUCTION
Gastric epithelial dysplasia is considered to be a precursor le-
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sion of gastric cancer, and has various clinical courses. Some 
progress to adenocarcinoma, whereas others persist unchanged 
for many years.
1,2 Moreover, without uniform and definite cri-
teria for the diagnosis of gastric epithelial dysplasia, treatment 
is inconsistent and often results in over-treatment of gastric 
epithelial dysplasia by surgical resection.
3-5 In an attempt to 
resolve this problem, the revised Vienna classification has been 
proposed,
6,7 providing a consensus on guidelines for clinical 
management. The removal of category 3 (low grade dysplasia) 
lesions may not be necessary, whereas the removal of category 
4 lesions (high grade dysplasia and intramucosal cancer) must 
be obligatory. But this classification is not perfect and there are 
frequently cases that do not easily fit into the diagnostic cat-
egories of the revised Vienna classification. Approximately 15% 
to 30% of low grade dysplasia progress to high grade lesions 
and/or adenocarcinomas,
5,8 so this classification system needs 
a complementary marker. Moreover, the inter-observer and 
intra-observer variation of histopathologists should be never 
neglected in the diagnosis of gastric epithelial dysplasia and in-
tramucosal cancer. 
The goal of this study was to investigate the level of LINE-
1 methylation in gastric epithelial dysplasia and intramucosal 
cancer samples as well as the level of LINE-1 methylation in the 
adjacent mucosa. The results could potentially be of clinical in-
terest and we hoped to provide the pathologist with an objective 
marker to distinguish between low grade dysplasia and high 
grade dysplasia or between high grade dysplasia and intramu-
cosal cancer. 
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MATERIALS AND METHODS
All tissues were excised by therapeutic endoscopic mucosal 
resection. The diagnosis of tissue sample was confirmed by two 
different histopathologists according to the revised Vienna clas-
sification; when they disagreed, the tissue sample was excluded 
from the study. The lesions were histopathologically assigned 
to divide into 3 groups according to the revised Vienna clas-
sification system: low grade dysplasia (category 3), high grade 
dysplasia (category 4.1) and intramucosal cancer (categories 4.2, 
4.3, and 4.4). 
All normal tissues had grossly intact mucosa and were at 
least 1 cm from the mucosal lesion; they were obtained by gas-
tric biopsy just after an endoscopic mucosal resection. The mi-
croscopic examination showed no evidence of malignant cells. 
Each patient was classified as Helicobacter pylori (H. pylori) 
positive or negative according to the histological results. In the 
present study, the resection specimen and gastric biopsy of sur-
rounding mucosa were stained with hematoxylin and eosin and 
silver stains. To assess H. pylori state accurately, two biopsies 
were taken both from antrum and corpus after 4 weeks of the 
endoscopic resection. We evaluated with CLO test or histological 
examination. 
1. DNA extraction 
Four-micrometer-thick tissue sections from the dysplasia/can-
cer and normal tissues were placed on a glass slide and stained 
with hematoxylin and eosin. The diagnosis of the tissue samples 
was confirmed by two different histopathologists. Prior to DNA 
extraction, all the microdissected tumor sites were checked for 
the tumor cell contents ≥70% using a stereomicroscope under a 
×40 magnification. 
Two ten-micrometer-thick tissue sections from cancer sam-
ples and normal tissues were placed on glass slides. The tissue 
sections were added by xylene (1 mL), incubated for 10 minutes 
and repeated 3 times. These were then dehydrated in graded 
ethanol solutions (100% ethanol, 1 mL), dried without a cover 
glass for 10 minutes and repeated three times. The DNA was 
extracted from the tissues with 20 uL of extraction buffer (100 
mmol/L Tris-HCl; 2 mmol/L ethylene diamine tetraacetic acid 
[EDTA], pH 8.0; 400 ug/mL of proteinase K) at 55°C overnight. 
The tubes were boiled for 7 minutes to inactivate the protein-
ase K, and cooling on ice. The solution was added by 20 uL 
(Phenol:Chloloform:Isoamyl alcohol, 25:24:1) and centrifuged 
at 12,000 rpm, 4
P$ for 5 minutes. This process was de-protein-
ization to extract DNA of tissue. The supernatant was added by 
ethanol (1 mL, 100%) and the tube was gently inverted. It was 
incubated at -20
P$ for 10 minutes and centrifuged at 12,000 
rpm, 4
P$ for 5 minutes. DNA pellet was made by washing with 
ethanol (1 mL, 75%) and centrifuged at 14,000 rpm for 5 min-
utes. The pellet was dissolved by adding 20 uL of dextrose wa-
ter, and then 1 uL of this extract was used for each polymerase 
chain reaction (PCR) amplification.
2. Assessment of LINE-1 methylation status
A modified long interspersed nucleotide elements-combined 
bisulfite restriction analysis (COBRA LINE-1) method was used 
to analyze LINE-1 methylation status of the cancers and normal 
mucosa.
9-11 This method is based on the principle that cytosine 
in DNA is converted to uracil when DNA is treated with sodium 
bisulfite, whereas methylated cytosine is protected from the 
conversion. Thus, the methylated and unmethylated cytosine 
could be distinguished by digestion with a restriction enzyme 
that recognizes sequences containing CpG. The extracted 
DNA was treated with sodium bisulfite, and isolated using the 
EZ DNA methylation kit (Zymo Research, Orange, CA, USA). 
Bisulfite-treated DNA was amplified by 40 cycles of PCR with 
two primers, LINE3 (5V-GYGTAAGGGGTTAGGGAGTTTTT) and 
LINE4 (5V-AACRTAAAACCCTCCRAACCAAATATAAA), at an 
annealing temperature of 50
P$. The PCR products were digested 
with the TaqI restriction enzyme, which recognizes TCGA, for 1 
hour at 65
P$, and then were separated by electrophoresis on 2% 
agarose gels. The densities of the digested and undigested bands 
were obtained by scanning with Gel Doc XR (Bio-Rad, Hercules, 
CA, USA) and scoring with Quantity One Software (Bio-Rad). 
The ratio of the digested fragments (80 bp) derived from the 
methylated DNA divided by the sum of the digested fragments 
and the undigested fragments (160 bp) derived from the un-
methylated DNA represents the fractional methylation (expressed 
as a percentage) at the LINE TaqI site.
3. Statistical analysis
For the quantitative variables, the mean and its standard error 
were calculated. For the qualitative variables, the percent and 
its 95% confidence interval (CI) were calculated. We used the χ
2 
test to analyze the association between the H. pylori status and 
other baseline characteristics. For comparison of age and the 
level of LINE-1 methylation we used the unpaired t test and one 
way ANOVA. The diagnostic yield of the level of LINE-1 meth-
ylation, for the prediction of premalignant or early cancer le-
sions, was calculated using the area under the receiver operating 
characteristic (ROC) curve. The area under the ROC curve (AUC) 
is the measure of separation of two probability distributions: 
excellent for AUC values greater than 0.9, good for 0.8 to 0.9, 
fair for 0.7 to 0.8, poor for 0.6 to 0.7, and failure for values less 
than 0.6. We used the SPSS statistical package (version 12.0.1; 
SPSS Inc., Chicago, IL, USA) for all analyses.
RESULTS
Total 145 tissue samples were examined and thirteen tissue 
samples were excluded because of disagreement on diagnosis 
and inappropriate preparation of tissue. The concordance rate 
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were analyzed. Seventy nine cases of gastric epithelial dysplasia 
and 53 intramucosal carcinoma tissue samples were paired with 
adjacent normal mucosal tissues. Forty-one patients (51.9%) 
with gastric epithelial dysplasia and 33 patients (62.3%) with 
intramucosal carcinoma had associated H. pylori infection 
(p=0.24). When the gastric epithelial dysplasia was divided ac-
cording to the revised Vienna classification, 49 tissues were low 
grade and 30 were high grade dysplasia.
The level of LINE-1 methylation in the gastric epithelial le-
sions and adjacent normal mucosa, from the same subject, was 
examined by a modified COBRA LINE-1 method (Fig. 1). The 
gastric epithelial dysplasia and cancer tissues had significantly 
lower levels of LINE-1 methylation than the adjacent normal 
tissues (Fig. 2). In gastric epithelial dysplasia, the dysplasia le-
sion showed a significantly lower LINE-1 methylation level 
(42.85±0.63%) compared to normal epithelium (46.35±0.69%) 
(p<0.01). In intramucosal cancer, the cancer lesion showed a 
significantly lower LINE-1 methylation level (40.23±0.92%) 
compared to normal epithelium (45.94±1.78%) (p<0.01). When 
the dysplastic lesions with H. pylori infection compared to the 
lesions without infection, there was no significant difference 
(42.46±0.88 and 43.22±0.89, p=0.27). 
The tissue samples were divided into three groups according 
to the revised Vienna classification: low grade dysplasia, high 
grade dysplasia and intramucosal cancer. Forty nine patients 
with low grade dysplasia, 30 patients with high grade dysplasia 
and 53 with intramucosal cancer were evaluated (Table 1). The 
high grade dysplasia and intramucosal cancer (category 4) had 
Fig. 1. Assessment of LINE-1 hypomethylation status using the 
COBRA-LINE-1 method. Calculations are based on the ratio of the 
digested bands divided by the sum of the digested and undigested 
bands, as described in the materials and methods section. 
Fig. 2. LINE-1 hypomethylation levels in gastric epithelial dysplasia 
and intramucosal cancer. When compared to adjacent normal mu-
cosa, gastric epithelial dysplasia and cancer tissues have significantly 
lower LINE-1 methylation levels. Box plots illustrate median values, 
25th and 75th percentiles, and outliers on a linear scale. The unpaired 
t-test is applied for nonparametric statistical analysis, and a p value 
of less than 0.05 is considered significant. 
N, normal; T, tumor.
Table 1. Basal Characteristics of the Enrolled Patients
Low grade 
dysplasia 
(n=49)
High grade 
dysplasia 
(n=30)
Intramucosal 
cancer (n=53)
p-
value 
Age 62.70±1.15 63.90±1.52 63.05±1.68   0.07
Sex
  Male
  Female
26
23
23
  7
33
53
<0.01
H. pylori infection (%) 26 (53.1) 15 (50.0) 33 (62.3) <0.01
LINE-1 methylation level , %
  Normal
  Tumor
45.95±0.69
45.51±0.65
47.41±2.84
38.52±0.76
45.94±1.78
40.23±0.92
  0.08
<0.01
Fig. 3. LINE-1 hypomethylation levels in gastric epithelial neopla-
sias categorized using the revised Vienna classification. When tissue 
samples are divided into three groups according to the revised Vienna 
classification, high-grade dysplasia and intramucosal cancer (category 
4) shows significantly lower LINE-1 methylation levels than low-
grade dysplasia (category 3). Box plots illustrate median values, 25th 
and 75th percentiles, and outliers on a linear scale. An unpaired t test 
and one way ANOVA are applied for nonparametric statistical analy-
ses, and a p value of less than 0.05 is considered significant. 152  Gut and Liver, Vol. 5, No. 2, June 2011
lower level of LINE-1 methylation than the low grade dysplasia 
(category 3) (Fig. 3). However, there was no difference between 
the high grade dysplasia and the intramucosal cancer with re-
gard to the LINE-1 methylation level (p=0.21). 
We checked the reproducibility of this method by retest reli-
ability, which measured stability over time. It was administering 
the same test to the same subjects at two points in time. For 
continuous data, consensus was measured by intraclass correla-
tion (ICC). We performed the quantitative methylation-specific 
PCR three times or more, and the data exhibited a high ICC (0.82; 
95% CI, 0.74 to 0.88). Also, we evaluated the level of LINE-1 
methylation for the assessment of premalignant lesions. ROC 
curve analysis differentiated the high grade dysplasia/intramu-
cosal cancer (categoty 4) from the low grade dysplasia (category 
3). The ROC curve represents the specificity and sensitivity of 
the diagnostic criteria for high grade dysplasia/intramucosal 
cancer. The area under the ROC curve (AUC) measures the over-
all performance of a diagnostic test and is interpreted as the 
average sensitivity for all possible values of specificity. The re-
sults showed that high grade dysplasia and intramucosal cancer 
were accurately diagnosed using the LINE-1 methylation level 
(AUC=0.82; 95% CI, 0.74 to 0.88) (Fig. 4).
DISCUSSION
Epigenetics is the study of the modification of gene expres-
sion without change of the underlying DNA sequence. The best-
known epigenetic marker is DNA methylation.
12-14 In cancer 
cells, DNA methylation changes are characterized by regional 
CpG island hypermethylation and generalized genomic hy-
pomethylation. Although both kinds of changes are observed 
simultaneously, these two changes are thought to be indepen-
dent events.
15 Several studies suggest that genome wide hypo-
methylation generally arises earlier and is strongly linked to 
chromosomal instability, whereas hypermethylation occurs in 
promoters and is usually a later event.
16-19 Moreover, during the 
development of a neoplasm, the level of methylation decreases 
as the lesion progresses from a benign proliferation of cells to 
an invasive cancer.
19-21 In gastric carcinogenesis, changes in hu-
man DNA methylation appear to be an early molecular event, 
and most of the methylation studies have focused on aberrant 
methylation of tumor associated genes.
22-24 However, there is 
limited data currently available on the level of global DNA 
methylation in precursor lesions of gastric cancer.
25,26 Differen-
tial level of global DNA methylation between dysplastic lesion 
and early cancer in multistep gastric carcinogenesis has not 
been described in the literature.
LINE-1, a highly repeated interspersed human retrotransposon, 
is ubiquitous and constitutes approximately 17% of the human 
genome. Its methylation status reflects the genome wide meth-
ylation level. LINE-1 has been shown to be responsible for the 
overall losses of DNA methylation, and COBRA LINE-1 method 
is suitable for indirectly evaluating whole genome hypometh-
ylation.
10,16 The levels of LINE-1 methylation were significantly 
different among different tissue types. Most carcinomas includ-
ing breast, colon, bladder, liver, prostate and stomach, revealed 
a greater level of LINE-1 hypomethylation than their normal 
tissue counterparts, whereas the levels in thyroid, esophageal tis-
sue and lymphoma did not discriminate between the tumor and 
normal tissue.
10 Since routine formalin-fixed paraffin-embedded 
tissues are suitable of the COBRA LINE-1 analysis, identification 
of this molecular event might be a useful adjunct to the standard 
pathological examination of the excised specimen.
In the present study, we applied COBRA LINE-1 method to ef-
ficiently and quantitatively evaluate LINE-1 methylation status of 
gastric epithelial dysplasia and intramucosal cancer. We evaluated 
how global hypomethylation evolves during the multistep process 
of carcinogenesis of the gastric cancer. The results showed that 
gastric epithelial dysplasia and cancer tissues had significantly 
lower level of LINE-1 methylation than adjacent normal tissues. 
In addition, the level of LINE-1 methylation correlated well with 
gastric lesions defined by the revised Vienna classification. It 
might substantiate the distinction between the low grade and 
high grade dysplasia/intramucosal cancer. Moreover, the repro-
ducibility of the test showed relatively high ICC value (0.816; 95% 
CI, 0.736 to 0.876). These findings were very promising. Next, we 
plan to determine whether the precancerous lesions have differ-
ent global DNA methylation level depending on whether there 
is invasive carcinoma or not. Unfortunately, the sample size of 
this study was too small and validation study was not performed. 
Also, it should be necessary to evaluate a methylation profile be-
tween low grade dysplasia and reactive changes.
Correa suggested a human model of gastric carcinogenesis 
and postulated that hyperproliferation caused by H. pylori gas-
tritis is the starting point of a sequence of events that leads to 
gastric cancer.
27 Previously several investigators proposed that 
aberrant DNA methylation of gastric mucosa infected by H. py-
Fig. 4. Receiver operating characteristic (ROC) curve for the diagnosis 
of high-grade dysplasia/intramucosal cancer. Gastric high-grade dys-
plasia and intramucosal cancer are accurately diagnosed using LINE-1 
methylation levels (AUC, 0.82; 95% confidence interval, 0.74 to 0.88).Lee JR, et al: LINE-1 Hypomethylation of Gastric Epithelial Neoplasia  153
lori was possibly associated with gastric cancer risk.
28,29 In recent 
study, the association between methylation abnormality and H. 
pylori infection is debatable. The levels of LINE-1 methylation 
decrease from the chronic gastritis to gastric cancer stages, re-
gardless of the status of H. pylori infection.
26 Our results showed 
that lesions with H. pylori infection had a slightly lower level of 
LINE-1 methylation compared to the lesions without H. pylori 
infection; however, these differences were not significant. It had 
several limitations that a small number of patients were en-
rolled and the controlled group was absent. We did not consider 
whether the enrolled patients had past exposure to H. pylori. 
In summary, the level of LINE-1 methylation might be con-
sidered as a useful diagnostic tool for the differentiation of high 
grade dysplasia/intramucosal cancer, and help to determine the 
appropriate treatment strategy for patients. 
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